The largest database of trusted experimental protocols

7 protocols using anti cd3 2c11

1

Activation and Polarization of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells were activated and cultured in RPMI-1640 medium containing 10% FCS, 50 U/ml Penicillin, 50 µg/ml Streptomycin, 50 µg/ml Gentamycin, 1 nM Sodium Pyruvate, 10 µM Hepes, 2 mM L-glutamine, and 50 µM 2-Mercaptoethanol (complete RPMI). Purified naive T cells were stimulated in 24-well plates (3–5 × 106 cells/well) precoated with the indicated concentrations of anti-CD3 (2C11; Bio-XCell) and anti-CD28 (37.51; Bio-XCell) in PBS in complete medium containing 50–100 U/ml recombinant murine IL-2 (eBioscience) for the indicated times. In some experiments, the class I PI3K inhibitor ZSTK474 (Sigma) was added as indicated. For restimulation experiments, cells were stimulated for 2 d with 1 µg/ml plate-bound anti-CD3/anti-CD28 + IL-2, then removed from stimulus and placed in complete media (without IL-2) overnight before restimulation with plate-bound anti-CD3 as indicated. For polarization of CD4+ T cells into TH1 and TH2 cells, total CD4+ T cells were activated with plate-bound anti-CD3 and anti-CD28 in media containing 200 U/ml IL-2 supplemented with 10 ng/ml IL-12 (eBioscience) and 20 µg/ml anti–IL-4 (11B11; Bio-XCell) for TH1 polarization or 100 ng/ml IL-4 (eBioscience) and 40 µg/ml anti–IFN-γ (XMG1.2; Bio-XCell) for TH2 polarization.
+ Open protocol
+ Expand
2

Robust T Cell Activation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Polyclonal T cells were activated ex vivo as described previously (Estin et al., 2017 (link)). Briefly, isolated T cells were activated with plate-bound anti-CD3 (2C11, 2 μg/well of 24 well plate) and soluble anti-CD28 (PV-1) (2 μg/mL) antibodies (both from BioXCell) in the presence of irradiated CD45.1/.1 feeder splenocytes for two days in R10. Cells were then removed from the plate and cultured with 10 U/mL recombinant human interleukin 2 (rIL2, AIDS Research and Reference Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, from M. Gately, Hoffmann-La Roche) for 3 days with addition of fresh R10 media and rIL2 on day 4 post-activation. By day 5, all CD45.1/.1 irradiated splenocytes have died. Prior to use dead cell and debris were removed from the culture by Histopacque-1119 (Millipore Sigma) density gradient.
+ Open protocol
+ Expand
3

Differentiation of Naïve CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphocytes from spleen and dLN were pooled and sorted using a Reflection (i-Cyt). Sorted naïve CD4+ T cells (CD4+CD25CD62L+CD44) were activated in vitro for 4–5 days with 2 μg/ml anti-CD3 (2C11; Bio X Cell), 2 μg/ml anti-CD28 (37.51; Bio X Cell), human TGF-β1 (2 ng/ml, R&D) and mouse IL-6 (20 ng/ml, BD Biosciences). Cytokine expression was assessed after PMA/ionomycin stimulation as described above.
+ Open protocol
+ Expand
4

Differentiation of Naïve CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphocytes from spleen and dLN were pooled and sorted using a Reflection (i-Cyt). Sorted naïve CD4+ T cells (CD4+CD25CD62L+CD44) were activated in vitro for 4–5 days with 2 μg/ml anti-CD3 (2C11; Bio X Cell), 2 μg/ml anti-CD28 (37.51; Bio X Cell), human TGF-β1 (2 ng/ml, R&D) and mouse IL-6 (20 ng/ml, BD Biosciences). Cytokine expression was assessed after PMA/ionomycin stimulation as described above.
+ Open protocol
+ Expand
5

Differentiation of Murine T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naive CD4+CD25CD62LhiCD44lo T cells from spleens and lymph nodes were isolated using a FACSAria sorter (BD Biosciences). Purified naive T cells were stimulated with 2 μg/mL plate-bound anti-CD3 (2C11, Bio X Cell) and 2 μg/mL anti-CD28 (37.51, Bio X Cell) in the presence of 5 μg/mL anti–IFN-γ (XMG1.2, Bio X Cell), 5 μg/mL anti–IL-4 (11B11, Bio X Cell), and 40 U/mL IL-2 (Peprotech) for the generation of Th0 cells; 20 ng/mL IL-12 (Peprotech), 5 μg/mL anti–IL-4, and 40 U/mL IL-2 for the generation of Th1 cells; 10 ng/mL IL-4 (Peprotech), 10 μg/mL anti–IFN-γ and 40 U/mL IL-2 for the generation of Th2 cells; 1 ng/mL TGF-β1 (Peprotech), 10 ng/mL IL-6 (Peprotech), 5 μg/mL anti–IFN-γ, and 5 μg/mL anti–IL-4 or 10 ng/mL IL-23, 10 ng/mL IL-1β (Peprotech), 10 ng/mL IL-6, 5 μg/mL anti–IFN-γ, and 5 μg/mL anti–IL-4 for the generation of Th17 cells; and 1 ng/mL TGF-β1, 5 μg/mL anti–IFN-γ, 5 μg/mL anti–IL-4, and 40 U/mL IL-2 for the generation of iTregs. Cells were cultured in complete medium (RPMI medium containing 10% FBS, supplemented with penicillin-streptomycin, HEPES, l-glutamine, sodium pyruvate, and 2-mercaptoethanol) for 3–5 days, followed by intracellular staining and RNA preparation.
+ Open protocol
+ Expand
6

T cell Activation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
anti-CD3 (2C11) and anti-CD28 (PV1) were from BioXCell. Anti-CrkL (SC-319) was from Santa Cruz. anti-CD3-FITC was from E-biosciences. Anti-Crk (#610036), Anti-CD8-FITC, anti-CD3, anti-CD45.1, anti-H-2Kb-Pacific Blue, anti-CD45.2-APC and LIVE/DEAD Fixable Aqua Dead Cell Stain Kit were from BD Bioscience. Secondary antibodies conjugated to appropriate fluorophores and AlexaFluor 488-conjugated phalloidin were obtained from Molecular Probes. Luciferin was purchased from Perkin Elmer and Gold Bio. Recombinant mouse ICAM-1-Fc was from R&D Systems.
+ Open protocol
+ Expand
7

CD4 T cell purification and activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To purify CD4 T cells, splenocytes and lymph node cells were stained with a biotin conjugated anti-CD4 antibody to enrich CD4 T cells using a magnetic Biotin-selection kit (Stem cell). Purified CD4 T cells were activated with plate-bound anti-Hamster IgG (MP Biomedicals) and anti-CD3 (2C11, Bio X cell) +anti-CD28 (37N, Bio X cell) in the presence of anti-IL-4 (5 mg/ml; 11B11, Bio X cell) and IL-12 (2 ng/ml; PeproTech) in T cell medium (RPMI 1640, 10% FBS, 1x antibiotics, 1x non-essential amino acid and 50 mM b-mercaptoethanol).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!